Glimepiride (Hoe490) inhibits the rilmakalim induced decrease in intracellular free calcium and contraction of isolated heart muscle cells from guinea pigs to a lesser extent than glibenclamide

International Journal of Cardiology

Volumn 72, Issue 1, 1999, Pages 53-63

  Olbrich, Hans Georg ^a   Müller, Marcus ^a   Lindner, Suzana ^a   Henke, Bettina ^a   Zarse, Markus ^a   Riehle, Mathis ^a   Oremek, Gerhard ^a   Mutschler, Ernst ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Calcium (cellular); Cardiac myocytes; Contractile function; Potassium channel opener; Sulfonylureas

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; FURA 2; GLIBENCLAMIDE; GLIMEPIRIDE; LACTATE DEHYDROGENASE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; RILMAKALIM; SULFONYLUREA;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; ELECTROSTIMULATION; ENZYME RELEASE; FLUORESCENCE; GUINEA PIG; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE; IMAGE ANALYSIS; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM; CHROMANS; GLYBURIDE; GUINEA PIGS; HYPOGLYCEMIC AGENTS; MYOCARDIAL CONTRACTION; POTASSIUM; POTASSIUM CHANNELS; PYRROLIDINES; SULFONYLUREA COMPOUNDS;

EID: 0033573198     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00158-8     Document Type: Article

References (48)

1. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: II. Mortality results. Diabetes 1970;19(Suppl. 2):789-830.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. O'Keefe JH, Blackstone EH, Sergeant P, McCallister BD. The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery. Eur Heart J 1998;19:1696-703.
4. Geisen K, Vegh A, Krause E, Papp JG. Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm Metab Res 1996;28:496-507.
5. Noma A, Shibasaki T. Membrane current through adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells. J Physiol 1985;363:463-80.
6. + channels in cardiac muscle. Nature 1983;305:147-8.
7. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-81.
8. Grover GJ, Sleph PG, Dzwonczyk S. Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine-1 receptors. Circulation 1992;86:1310-6.
9. Imamura Y, Tomoike H, Narishige T, TAkahashi T, Kasuya H, Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol 1992;263:H399-404.
10. DÁlonzo AJ, Sewter JC, Darbenzio RB, Hess TA. Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted anesthetized dogs. Naunyn-Schmiedeberg's Arch Pharmacol 1995;352:222-8.
11. Wolleben CD, Sanguinetti MC, Siegl PK. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J Mol Cell Cardiol 1989;21:783-8.
12. Geisen K. Special pharmacology of the new sulfonylurea glimepiride. Arzneim- Forsch/Drug Res 1988;38:1120-30.
13. Ballagi-Pordány G, Németh M, Aranyi Z, Kekesi E, Koltai MZ, Papp G, Pogatsa G. Effect of glimepiride on the electrical activity of isolated rabbit heart muscle. Arzneim-Forsch/Drug Res 1992;42:111-3.
14. Jiang C, Mochizuki S, Poole-Wilson PA, Harding SE, MacLeod KT. Effect of levcromakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes. Cardiovasc Res 1994;28:851-7.
15. + channels. J Pharmacol Exp Ther 1994;268:818-25.
16. Piper HM, Probst I, Schwartz P, Hütter JF, Spiekermann PG. Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol 1982;14:397-412.
17. Horwitz LD, Leff JA. Catalase and hydrogen peroxide cytotoxicity in cultured cardiac myocytes. J Mol Cell Cardiol 1995;27:909-15.
18. Riehle M, Bereiter-Hahn J. Kontraktilität und Sauerstoffverbrauch bei Kardiomyozyten in Kultur. Mitteilungen Wissenschaft Technik 1994;10:226-31.
19. Williams D, Fogarty K, Tsien R, Fay F. Calcium gradients in single smooth muscle cells revealed by the digital imaging microscope using Fura-2. Nature 1985;318:558-60.
20. Cobbold PH, Rink TJ. Fluorescence and bioluminescence measurement of cytoplasmic free calcium. Biochem J 1987;248:313-28.
21. Li Q, Altschuld R, Stokes B. Quantitation of intracellular free calcium in single adult cardiomyocytes by Fura-2 fluorescence microscopy: Calibration of Fura-2 ratios. Biochem Biophys Res Commun 1987;147:120-6.
22. Geerts H, Nuydens R, Nuyens R, Ver Donck L. The effect of flunarizine on intracellular calcium in isolated rat cardiomyocytes. A digital image processing study. Cardiovasc Res 1989;23:797-806.
23. Grynkiewicz G, Poenie M, Tsien R. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
24. Sachs L. Angewandte Statistik, 7th Edn., Berlin: Springer Verlag, 1992.
25. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:65-75.
26. Carmeliet E. Potassium channels in cardiac cells. Cardiovasc Drugs Ther 1992;6:305-12.
27. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 1991;261:H1675-86.
28. Keung EC, Li Q. Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes. J Clin Invest 1991;88:1772-7.
29. ATP channels in skeletal muscle by intracellular protons. Nature 1990;343:375-7.
30. ATP channel. Am J Physiol 1994;266:H829-39.
31. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
32. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993;27:617-22.
33. Schulz R, Rose J, Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol 1994;267:H1341-52.
34. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124 36.
35. Garlind KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, Dálonnzo AJ, Lodge NJ, Smith MA, Grover GJ. Cardioprotective effect of diaxozide and its interaction with mitochondrial ATP-sensitive K + channels. Possible mechanism of cardioprotection. Circ Res 1997;81:1072-82.
36. IsenberG G, Vereecke J, van der Heyden G, Carmeliet E. The shortening of the action potential by DNP in guinea-pig ventricular myocytes is mediated by an increase of a time-independent K conductance. Pfluegers Arch 1983;397:251-9.
37. + channels in guinea-pig cardiac myocytes. Pflügers Arch 1989;414:669-75.
38. ATP channels in isolated heart cells of the guinea-pig. J Physiol 1992;454:339-57.
39. + channels in isolated cardiac myocytes. Biochem Biophys Res Commun 1988;154:620-5.
40. + channels in mammalian ventricular myocytes. Am J Physiol 1989;257:H1551-9.
41. + channels. Circ Res 1991;69:1152-8.
42. Krause E, Englert H, Gögelein H. Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Pflügers Arch 1995;429:625-35.
43. + channels for potassium-channel-openers. FEBS Lett 1993;325:276-80.
44. Kramer W, Müller G, Geisen K. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells. Horm Metab Res 1996;28:464-8.
45. Ratheiser K, Korn A, Waldhäusl W, Komjah M, Vierhapper H, Badian M, Malerczyk V. Dose relationship of stimulated insulin production following intravenous application of glimepiride in healthy man. Arzneim-Forsch/Drug Res 1993;43:856-8.
46. Groop L, Luzi L, Melander A, Groop PH, Ratheiser K, Simonson DC, DeFronzo RA. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Diabetes 1987;36:1320-8.
47. Lehr KH, Damm P. Simultaneous determination of the sulphonylurea glimepiride and its metabolites in human serum and urine by high-performance liquid chromatography after pre-column derivatization. J Chromatogr 1990;526:497-505.
48. Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, HarriS S, Burger W. Sulfonylureas and ischemic preconditioning: A double blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 1999;20:439-46.